"Siemens" fructosamine reagent group - Taiwan Registration 61f3c9c0942cd59ed7f5295ff38189b8
Access comprehensive regulatory information for "Siemens" fructosamine reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 61f3c9c0942cd59ed7f5295ff38189b8 and manufactured by RANDOX LABORATORIES LIMITED;; SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including RANDOX LABORATORIES LTD.;; Siemens Healthcare Diagnostics Inc., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
61f3c9c0942cd59ed7f5295ff38189b8
DHA05602591602
Product Details
This product is used in conjunction with the ADVIA chemical system (ADVIA 1200, 1650/1800 and 2400) to quantify the concentration of glycosylated protein (fructosamine) in human serum or plasma for in vitro diagnostic use only.
B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
A.1150 calibration;; B.7470 Analysis of glycosylated hemoglobin
Input;; Contract manufacturing
Dates and Status
Mar 13, 2014
Mar 13, 2029